Patents by Inventor Kanu Patel

Kanu Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10537536
    Abstract: A formulation and method for delivery of bioactive substances when applied to, or within, the skin or other exterior region of a mammal. for example, a patient, includes a vasoactive agent; an osmolyte; and an active ingredient. The formulation is sufficiently hygroscopic so as to create a condition of hypertonicity when absorbed by the skin. When the formulation is applied to the skin, the vasoactive agent can be delivered to the dermis so as to contact the vasculature of a patient.
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: January 21, 2020
    Assignee: BioChemics, Inc.
    Inventors: Stephen G. Carter, Zhen Zhu, Kanu Patel, John J. Masiz
  • Publication number: 20200009095
    Abstract: Set forth herein is a preparation of ibuprofen (2-(4-isobutylphenyl) propionic acid) in the free acid form that is suitable for topical administration. The topical ibuprofen formulation is prepared by dissolving the free acid form of ibuprofen, or preparing a homogeneous suspension of the free acid form of ibuprofen, in the presence of a pharmaceutically acceptable solvent so as to produce a topical drug formulation compatible with the penetration of 2-(4-isobutylphenyl) propionic acid through the skin tissue. Topical formulations of ibuprofen can be based on a pharmaceutically acceptable solvent such as, e.g., a pyrrolidone solvent or dimethylacetamide.
    Type: Application
    Filed: September 19, 2019
    Publication date: January 9, 2020
    Inventors: Stephen G. Carter, Zhen Zhu, Kanu Patel, Diane L. Kozwich
  • Publication number: 20190255133
    Abstract: The present invention provides a topical formulation including (i) comfrey or a comfrey-derived compound, or an analogue or derivative thereof and (ii) a penetration enhancer, and optionally including tannic acid, or an analogue or derivative thereof. The present invention also provides a topical formulation including (i) comfrey or a comfrey-derived compound, or an analogue or derivative thereof, and (ii) tannic acid, or an analogue or derivative thereof, optionally including a penetration enhancer. Also provided are kits and methods of prophylactic or therapeutic treatment of inflammatory and/or degenerative conditions using the combination of active ingredients as herein described.
    Type: Application
    Filed: April 29, 2019
    Publication date: August 22, 2019
    Applicant: Arthritis Relief Plus Ltd.
    Inventors: Larry MCKAY, Kanu PATEL, Robert John CAPON
  • Patent number: 10322155
    Abstract: The present invention provides a topical formulation including (i) comfrey or a comfrey-derived compound, or an analog or derivative thereof and (ii) a penetration enhancer, and optionally including tannic acid, or an analog or derivative thereof. The present invention also provides a topical formulation including (i) comfrey or a comfrey-derived compound, or an analog or derivative thereof, and (ii) tannic acid, or an analog or derivative thereof, optionally including a penetration enhancer. Also provided are kits and methods of prophylactic or therapeutic treatment of inflammatory and/or degenerative conditions using the combination of active ingredients as herein described.
    Type: Grant
    Filed: November 15, 2007
    Date of Patent: June 18, 2019
    Assignee: ARTHRITIS RELIEF PLUS LTD.
    Inventors: Larry McKay, Kanu Patel, Robert John Capon, Kay McKay
  • Patent number: 10322077
    Abstract: Methods and formulations for removing a tattoo by using a cell disrupter in combination with a vasodilator, and optionally one or more of an osmotic modifying agent, a chelation agent, and an occlusive modifying agent. Embodiments optionally further include using one or more of an antibiotic, anesthetic, penetration enhancer, excipient, carrier and vehicle.
    Type: Grant
    Filed: January 28, 2016
    Date of Patent: June 18, 2019
    Assignee: BioChemics, Inc.
    Inventors: Stephen G. Carter, Zhen Zhu, Kanu Patel, Diane L. Kozwich, Laura Stephens, John J. Masiz, David H. Donabedian
  • Publication number: 20170095433
    Abstract: Set forth herein is a preparation of ibuprofen (2-(4-isobutylphenyl) propionic acid) in the free acid form that is suitable for topical administration. The topical ibuprofen formulation is prepared by dissolving the free acid form of ibuprofen, or preparing a homogeneous suspension of the free acid form of ibuprofen, in the presence of a pharmaceutically acceptable solvent so as to produce a topical drug formulation compatible with the penetration of 2-(4-isobutylphenyl) propionic acid through the skin tissue. Topical formulations of ibuprofen can be based on a pharmaceutically acceptable solvent such as, e.g., a pyrrolidone solvent or dimethylacetamide.
    Type: Application
    Filed: December 19, 2016
    Publication date: April 6, 2017
    Inventors: Stephen G. Carter, Zhen Zhu, Kanu Patel, Diane Kozwich
  • Patent number: 9566256
    Abstract: A formulation and method for delivery of bioactive substances when applied to, or within, the skin or other exterior region of a mammal. for example, a patient, includes a vasoactive agent; an osmolyte; and an active ingredient. The formulation is sufficiently hygroscopic so as to create a condition of hypertonicity when absorbed by the skin. When the formulation is applied to the skin, the vasoactive agent can be delivered to the dermis so as to contact the vasculature of a patient.
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: February 14, 2017
    Assignee: Biochemics, Inc.
    Inventors: Stephen G. Carter, Zhen Zhu, Kanu Patel, John J. Masiz
  • Patent number: 9561174
    Abstract: Set forth herein is a preparation of ibuprofen (2-(4-isobutylphenyl) propionic acid) in the free acid form that is suitable for topical administration. The topical ibuprofen formulation is prepared by dissolving the free acid form of ibuprofen, or preparing a homogeneous suspension of the free acid form of ibuprofen, in the presence of a pharmaceutically acceptable solvent so as to produce a topical drug formulation compatible with the penetration of 2-(4-isobutylphenyl) propionic acid through the skin tissue. Topical formulations of ibuprofen can be based on a pharmaceutically acceptable solvent such as, e.g., a pyrrolidone solvent or dimethylacetamide.
    Type: Grant
    Filed: September 5, 2012
    Date of Patent: February 7, 2017
    Assignee: BioChemics, Inc.
    Inventors: Stephen G. Carter, Zhen Zhu, Kanu Patel, Diane Kozwich
  • Publication number: 20160235846
    Abstract: In a method for treating an affected skin region of a patient having a skin disorder, a vasodilation composition is applied to an affected skin region of a patient, the affected skin region exhibiting a skin disorder characterized by at least one abnormal blood vessel, and the affected skin region is then treated so as to non-invasively disrupt tissue architecture, e.g., by inducing ischemia, of the at least one abnormal blood vessel. A vasoconstriction composition can then be applied to the skin region to cause vasoconstriction of the at least one blood vessel in order to promote healing.
    Type: Application
    Filed: April 28, 2016
    Publication date: August 18, 2016
    Inventors: Stephen G. Carter, John J. Masiz, Laura Stephens, Zhen Zhu, Kanu Patel
  • Publication number: 20160213586
    Abstract: Methods and formulations for removing a tattoo by using a cell disrupter in combination with a vasodilator, and optionally one or more of an osmotic modifying agent, a chelation agent, and an occlusive modifying agent. Embodiments optionally further include using one or more of an antibiotic, anesthetic, penetration enhancer, excipient, carrier and vehicle.
    Type: Application
    Filed: January 28, 2016
    Publication date: July 28, 2016
    Inventors: Stephen G. Carter, Zhen Zhu, Kanu Patel, Diane L. Kozwich, Laura Stephens, John J. Masiz, David H. Donabedian
  • Publication number: 20160129116
    Abstract: A formulation and method for delivery of bioactive substances when applied to, or within, the skin or other exterior region of a mammal. for example, a patient, includes a vasoactive agent; an osmolyte; and an active ingredient. The formulation is sufficiently hygroscopic so as to create a condition of hypertonicity when absorbed by the skin. When the formulation is applied to the skin, the vasoactive agent can be delivered to the dermis so as to contact the vasculature of a patient.
    Type: Application
    Filed: December 28, 2015
    Publication date: May 12, 2016
    Inventors: Stephen G. Carter, Zhen Zhu, Kanu Patel, John J. Masiz
  • Publication number: 20160128957
    Abstract: A formulation and method for delivery of bioactive substances when applied to, or within, the skin or other exterior region of a mammal. for example, a patient, includes a vasoactive agent; an osmolyte; and an active ingredient. The formulation is sufficiently hygroscopic so as to create a condition of hypertonicity when absorbed by the skin. When the formulation is applied to the skin, the vasoactive agent can be delivered to the dermis so as to contact the vasculature of a patient.
    Type: Application
    Filed: January 15, 2016
    Publication date: May 12, 2016
    Inventors: Stephen G. Carter, Zhen Zhu, Kanu Patel, John J. Masiz
  • Patent number: 9278233
    Abstract: Methods and formulations for removing a tattoo by using a cell disrupter in combination with a vasodilator, and optionally one or more of an osmotic modifying agent, a chelation agent, and an occlusive modifying agent. Embodiments optionally further include using one or more of an antibiotic, anesthetic, penetration enhancer, excipient, carrier and vehicle.
    Type: Grant
    Filed: December 4, 2009
    Date of Patent: March 8, 2016
    Assignee: BioChemics, Inc.
    Inventors: Stephen G. Carter, Zhen Zhu, Kanu Patel, Diane L. Kozwich, Laura Stephens, John J. Masiz, David H. Donabedian
  • Patent number: 8802085
    Abstract: A method for treating a patient suffering from a wound, ulcer, or inflammation includes providing a topical formulation comprising a carrier and a combination of active ingredients that includes at least one retinoid and at least one blood vessel dilator, and applying the topical formulation to the skin of the patient to cause healing, accelerated healing or prevention of the wound, ulcer or inflammation. Additional active ingredients may include a promoter of mitochondrial function or an antioxidant.
    Type: Grant
    Filed: December 4, 2012
    Date of Patent: August 12, 2014
    Assignee: BioChemics, Inc.
    Inventors: Stephen G. Carter, Zhen Zhu, Kanu Patel, Diane L. Kozwich
  • Publication number: 20130245538
    Abstract: In a method for treating an affected skin region of a patient having a skin disorder, a vasodilation composition is applied to an affected skin region of a patient, the affected skin region exhibiting a skin disorder characterized by at least one abnormal blood vessel, and the affected skin region is then treated so as to non-invasively disrupt tissue architecture, e.g., by inducing ischemia, of the at least one abnormal blood vessel. A vasoconstriction composition can then be applied to the skin region to cause vasoconstriction of the at least one blood vessel in order to promote healing.
    Type: Application
    Filed: January 3, 2013
    Publication date: September 19, 2013
    Applicant: BIOCHEMICS, INC.
    Inventors: Stephen G. Carter, John J. Masiz, Laura Stephens, Zhen Zhu, Kanu Patel, David H. Donabedian
  • Patent number: 8367122
    Abstract: In a method for treating an affected skin region of a patient having a skin disorder, a vasodilation composition is applied to an affected skin region of a patient, the affected skin region exhibiting a skin disorder characterized by at least one abnormal blood vessel, and the affected skin region is then treated so as to non-invasively disrupt tissue architecture, e.g., by inducing ischemia, of the at least one abnormal blood vessel. A vasoconstriction composition can then be applied to the skin region to cause vasoconstriction of the at least one blood vessel in order to promote healing.
    Type: Grant
    Filed: June 11, 2009
    Date of Patent: February 5, 2013
    Assignee: BioChemics, Inc.
    Inventors: Laura Stephens, John J. Masiz, Stephen G. Carter, Zhen Zhu, Kanu Patel
  • Patent number: 8354116
    Abstract: The synthesis and use of bifunctional molecules to improve the topical and transdermal delivery efficiency of various types of therapeutic agents or agents designed to promote the transdermal delivery of those therapeutic agents either into the skin tissue or into the systemic circulation. Three major classes of molecules are covalently joined as bifunctional substances; chemical vasodilators, passive dermal penetration enhancers and therapeutic or diagnostic drugs. Chemical vasodilators may be delivered into the skin to increasing the blood flow in a tissue that has compromised circulation or they may be used as part of a delivery vehicle to promote the delivery of the drug. Passive dermal penetration enhancers are those chemicals that promote the passive penetration of drugs and other chemicals through the stratum corneum and epidermis of the skin tissue. Drugs and diagnostic agents are the third group of chemicals that are candidates for the linkage of molecules.
    Type: Grant
    Filed: June 18, 2007
    Date of Patent: January 15, 2013
    Assignee: BioChemics, Inc.
    Inventors: Stephen G. Carter, Kanu Patel, Zhen Zhu, Lixin Qiao
  • Patent number: 8343486
    Abstract: A method for treating a patient suffering from a wound, ulcer, or inflammation includes providing a topical formulation comprising a carrier and a combination of active ingredients that includes at least one retinoid and at least one blood vessel dilator, and applying the topical formulation to the skin of the patient to cause healing, accelerated healing or prevention of the wound, ulcer or inflammation. Additional active ingredients may include a promoter of mitochondrial function or an antioxidant.
    Type: Grant
    Filed: January 22, 2009
    Date of Patent: January 1, 2013
    Assignee: BioChemics, Inc.
    Inventors: Stephen G. Carter, Zhen Zhu, Kanu Patel, Diane L. Kozwich
  • Publication number: 20120329875
    Abstract: Set forth herein is a preparation of ibuprofen (2-(4-isobutylphenyl) propionic acid) in the free acid form that is suitable for topical administration. The topical ibuprofen formulation is prepared by dissolving the free acid form of ibuprofen, or preparing a homogeneous suspension of the free acid form of ibuprofen, in the presence of a pharmaceutically acceptable solvent so as to produce a topical drug formulation compatible with the penetration of 2-(4-isobutylphenyl) propionic acid through the skin tissue. Topical formulations of ibuprofen can be based on a pharmaceutically acceptable solvent such as, e.g., a pyrrolidone solvent or dimethylacetamide.
    Type: Application
    Filed: September 5, 2012
    Publication date: December 27, 2012
    Applicant: BioChemics, Inc.
    Inventors: Stephen G. Carter, Zhen Zhu, Kanu Patel, Diane L. Kozwich
  • Patent number: 7921404
    Abstract: A method is disclosed for electronically processing constraints rules defined in a previously developed first PCB design having a first constraints output file, to facilitate the development of a second PCB design having a second constraints output file. The second design has substantially identical topology to the first design and the second constraints output file comprises constraints for signals with identical attributes. The method includes several steps. Firstly, the board file of the first design is compared with the net list file of the second design to identify respective differences between the designs. On the basis of the established differences, a file attributes change report is generated. At least some data from the file attributes change report is stored into an attributes change file.
    Type: Grant
    Filed: December 11, 2007
    Date of Patent: April 5, 2011
    Assignee: International Business Machines Corporation
    Inventors: Anil Bindu Lingambudi, Ankur Kanu Patel, Saravanan Sethuraman, Diyanesh Vidyapoornachary Babu Chinnakkonda